Palatin Technologies
PTN
#10067
Rank
โ‚ฌ32.49 M
Marketcap
18,34ย โ‚ฌ
Share price
-3.24%
Change (1 day)
9,803.75%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -โ‚ฌ4.7 Million

According to Palatin Technologies's latest financial reports the company's current earnings are โ‚ฌ8.84 Million. In 2024 the company made an earning of -โ‚ฌ22.98 Million, an increase over its 2023 earnings that were of -โ‚ฌ27.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ4.7 Million-79.58%
2024 -โ‚ฌ22.98 Million-16.9%
2023 -โ‚ฌ27.65 Million5.99%
2022 -โ‚ฌ26.09 Million-13.7%
2021 -โ‚ฌ30.23 Million33.25%
2020 -โ‚ฌ22.69 Million-172.11%
2019 โ‚ฌ31.45 M2352.33%
2018 โ‚ฌ1.28 M-94.13%
2017 โ‚ฌ21.85 M-154.92%
2016 -โ‚ฌ39.8 Million3.67%
2015 -โ‚ฌ38.39 Million878%
2014 -โ‚ฌ3.93 Million-72.64%
2013 -โ‚ฌ14.35 Million-33.11%
2012 -โ‚ฌ21.45 Million77.71%
2011 -โ‚ฌ12.07 Million
2003 -โ‚ฌ20.44 Million29.93%
2002 -โ‚ฌ15.73 Million36.18%
2001 -โ‚ฌ11.55 Million
1999 -โ‚ฌ9.59 Million6.04%
1998 -โ‚ฌ9.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.61 B-699,817.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.03 B-294,318.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ0.54 B-13,374.02%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚ฌ10.24 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.13 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚ฌ0.11 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ43.1 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚ฌ25.15 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚ฌ47.38 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA